Dysphagia Clinical Trial
Official title:
Efficacy of Natural Ingredient to Improve the Swallowing Response of Patients With Oropharyngeal Dysphagia
Verified date | October 2017 |
Source | Nestlé |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Assessment of the improvement of the safety of the swallowing function under 3 natural ingredients known to be agonist of sensory receptors.
Status | Completed |
Enrollment | 104 |
Est. completion date | September 11, 2017 |
Est. primary completion date | June 12, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 55 Years and older |
Eligibility |
Inclusion Criteria: - Patients aged 55+ - Patients showing impaired safety of the deglutition during the V-VST (volume - viscosity swallow test): Cough oxygen desaturation =3% or voice change. - Neurodegenerative or ischemic/hemorrhagic cerebral cause (stroke) or elderly subjects Exclusion Criteria: - Patients radiated for treatment of head and neck cancer Idiosyncrasis - Allergy to food or medication, especially contrast products (iodine) - Major respiratory disease needing oxygen as standard treatment. - Any major and relevant abdominal, head and neck, or chest surgery within the three months preceding the study. - Have a high alcohol consumption (more than 2 drinks/day) - Subject who cannot be expected to comply with the study procedures, including consuming the test products. - Currently participating or having participated in another clinical trial during the month preceding the study - Patients with relevant mucosal damage or with in-mouth irritation - Patients with pacemaker or electrode implants - Epileptic patients |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital de Mataró | Mataró | Barcelona |
Lead Sponsor | Collaborator |
---|---|
Nestlé |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Improvement of the safety of the swallowing function, according to Rosenbek's scale | The maximum PAS score across the different boluses (5, 10 and 20 ml) during nectar series (with and without active ingredient) assessed during videofluoroscopic (VF) recording of radio-opaque bolus deglutition. | up to15 min after ingredient ingestion | |
Secondary | Swallowing safety-Prevalence of penetration | the prevalence of penetration in the population according to Rosenbek's PAS (scores of 2-5) , assessed during videofluoroscopic (VF) recording of radio-opaque bolus deglutition. |
up to15 min after ingredient ingestion | |
Secondary | Swallowing safety-Prevalence of aspiration | the prevalence of aspiration in the population according to Rosenbek's PAS (scores of 6-8), assessed during videofluoroscopic (VF) recording of radio-opaque bolus deglutition. | up to15 min after ingredient ingestion | |
Secondary | Efficacy of swallowing function-Severity of the amount of oral and pharyngeal residues | Severity of the amount of oral and pharyngeal residues, assessed during videofluoroscopic (VF) recording of radio-opaque bolus deglutition. | up to15 min after ingredient ingestion | |
Secondary | Efficacy of swallowing function-Prevalence of subjects with oral and pharyngeal residues | Prevalence of subjects with oral and pharyngeal residues, assessed during videofluoroscopic (VF) recording of radio-opaque bolus deglutition. | up to15 min after ingredient ingestion | |
Secondary | Efficacy of swallowing function-Time to upper oesophageal sphincter opening | Time to upper oesophageal sphincter opening, assessed during videofluoroscopic (VF) recording of radio-opaque bolus deglutition. | up to15 min after ingredient ingestion | |
Secondary | Efficacy of swallowing function-Time to laryngeal vestibule opening | Time to laryngeal vestibule opening, assessed during videofluoroscopic (VF) recording of radio-opaque bolus deglutition. | up to15 min after ingredient ingestion | |
Secondary | Efficacy of swallowing function-time to laryngeal vestibule closure | time to laryngeal vestibule closure, assessed during videofluoroscopic (VF) recording of radio-opaque bolus deglutition. | up to15 min after ingredient ingestion | |
Secondary | Modification of brain physiology response to sensory input: | Amplitude and latency of the 4 peaks of the pharyngeal sensory evoked potentials (PSEP) on EEG. | up to 20 min after ingredient ingestion | |
Secondary | Tolerability to the products (gastrointestinal comfort) using a questionnaire, assessed during EEG sessions (V3 and V4) to avoid capturing side effects of the contrast agent (as nausea). | using questionnaire | ponctually at the end of visits V3 and V4, after the EEG recording lasting about 30 min, during wich the product is ingested | |
Secondary | palatability using a questionnaire, assessed during EEG sessions (V3 and V4) | using questionnaire | ponctually at the end of visits V3 and V4, after the EEG recording lasting about 30 min, during wich the product is ingested |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03711474 -
Dysphagia Following Anterior Cervical Spine Surgery; Single Dose Steroid vs Saline (DysDexVSSal)
|
Phase 4 | |
Enrolling by invitation |
NCT04074356 -
Non-invasive Markers of Esophageal Function in Adults
|
N/A | |
Suspended |
NCT04349462 -
Post Critical Illness Dysphagia in the Intensive Care Unit
|
N/A | |
Not yet recruiting |
NCT05982977 -
Study on the Effect Mechanism of Acupuncture Combined With Swallowing Training in Oral Dysphagia of Stroke
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Active, not recruiting |
NCT03455608 -
PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer
|
N/A | |
Active, not recruiting |
NCT03604822 -
Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS
|
N/A | |
Recruiting |
NCT03682081 -
Interventions for Patients With Alzheimer's Disease and Dysphagia
|
N/A | |
Completed |
NCT05700838 -
Refining Cough Skill Training in Parkinson's Disease and Dysphagia
|
Phase 1 | |
Not yet recruiting |
NCT04064333 -
Slow-Stream Expiratory Muscle Strength Training for Veterans With Dysphagia Living in Long-term Care
|
N/A | |
Completed |
NCT02927691 -
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
|
Phase 2 | |
Not yet recruiting |
NCT02724761 -
Prophylactic Racemic Epinephrine in Anterior Cervical Discectomy and Fusion
|
N/A | |
Completed |
NCT01919112 -
Fostering Eating After Stroke With Transcranial Direct Current Stimulation
|
N/A | |
Completed |
NCT01370083 -
Tongue Pressure Profile Training for Dysphagia Post Stroke
|
Phase 2 | |
Withdrawn |
NCT01200147 -
Effectiveness of Rupture of Schatzki's Ring Using Biopsy Forceps Versus SIngle Dilation
|
N/A | |
Completed |
NCT01723358 -
Neuromuscular Electrical Stimulation (NMES) Treatment Technique Therapy in the Management of Young Infants With Severe Dysphagia
|
Phase 2 | |
Completed |
NCT00570557 -
Development of a Web-Based Course to Maintain Skills in Nurses Trained to Screen for Dysphagia
|
N/A | |
Recruiting |
NCT00166751 -
Sonographic Assessment of Laryngeal Elevation
|
N/A | |
Completed |
NCT01476241 -
Percutaneous Endoscopic Gastrostomy Tube Placement by Otorhinolaryngologist
|
N/A | |
Completed |
NCT00717028 -
Functional Endoscopic Evaluation of Swallowing
|
N/A |